| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-3542(98)00067-9 |
| P698 | PubMed publication ID | 10321575 |
| P50 | author | Tomas Bergström | Q39548937 |
| P2860 | cites work | Plaque-associated expression of human herpesvirus 6 in multiple sclerosis | Q24564496 |
| Epidemiologic evidence for multiple sclerosis as an infection | Q24615844 | ||
| Acute disseminated demyelination due to primary human herpesvirus-6 infection | Q28248912 | ||
| A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 | Q28283861 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Symptomatic Epstein-Barr virus infection and multiple sclerosis | Q33590581 | ||
| Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. | Q33591626 | ||
| Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. | Q33693860 | ||
| New non-invasive rapid diagnosis of herpes simplex virus encephalitis by quantitative detection of intrathecal antigen with a chemiluminescence assay | Q33733128 | ||
| Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy | Q34062792 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle | Q34290532 | ||
| Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
| Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis | Q34389343 | ||
| Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions | Q34729768 | ||
| Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group | Q34730962 | ||
| Varicella-Zoster Virus Reactivation without Rash | Q35229931 | ||
| Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection | Q35628687 | ||
| An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection | Q73271779 | ||
| Management of relapsing/remitting multiple sclerosis with copolymer 1 (Copaxone) | Q73821982 | ||
| Golli-MBP gene in multiple sclerosis susceptibility | Q74377586 | ||
| HHV-6 and multiple sclerosis | Q74539580 | ||
| In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis | Q74575052 | ||
| Detection of a gliotoxic activity in the cerebrospinal fluid from multiple sclerosis patients | Q74576359 | ||
| Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group | Q74785782 | ||
| Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients | Q77509015 | ||
| Evidence for multiple sclerosis as an infectious disease | Q45224811 | ||
| VIRUS ISOLATED FROM THE BRAIN OF A PATIENT WITH MULTIPLE SCLEROSIS. | Q45715083 | ||
| Lack of evidence for Marek's disease virus genomic sequences in leukocyte DNA from multiple sclerosis patients in Germany | Q45754355 | ||
| The varicella-zoster virus and multiple sclerosis | Q45754669 | ||
| The comparative anti-herpes simplex virus effects of human interferons | Q45756683 | ||
| A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis S | Q45758757 | ||
| Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. | Q45759086 | ||
| Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children | Q45761055 | ||
| Human T-cell lymphotropic virus tax and Epstein-Barr virus DNA in peripheral blood of multiple sclerosis patients during acute attack. | Q45762769 | ||
| Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations | Q45762873 | ||
| The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis | Q45764574 | ||
| Relationship of the strain and the intraocular amount of herpes simplex virus types 1 and 2 in the induction of anterior-chamber-associated immune deviation | Q45765585 | ||
| Herpes simplex virus type-2 infection by a footpad route results in neuronal death in mouse spinal ganglia | Q45775371 | ||
| A mouse model for varicella-zoster virus latency | Q45777379 | ||
| Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions | Q45782300 | ||
| The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis | Q45789666 | ||
| Virus-induced demyelination in herpes simplex virus-infected mice | Q45793041 | ||
| Intrathecal antibody synthesis to virus antigens in multiple sclerosis. | Q45795857 | ||
| Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture | Q45797173 | ||
| Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei | Q45800384 | ||
| Herpes-simplex virus as a cause of Bell's palsy | Q45827265 | ||
| Possible association of herpes simplex virus infection with demyelinating disease. | Q45828860 | ||
| Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis | Q45838680 | ||
| Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. | Q45842698 | ||
| Combined effects of acyclovir and human interferon-alpha on herpes simplex virus replication in cultured neural cells | Q45845006 | ||
| Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis | Q45845369 | ||
| Primary and recurrent herpes simplex virus type 2-induced meningitis | Q45851184 | ||
| Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro | Q45851288 | ||
| Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice | Q35673064 | ||
| Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin | Q35864140 | ||
| Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway | Q36317987 | ||
| Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis | Q36318289 | ||
| Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis | Q36596288 | ||
| Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis | Q36661594 | ||
| Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis | Q37097660 | ||
| Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction | Q39448449 | ||
| Evaluation of oral acyclovir therapy. | Q39495897 | ||
| T cells in multiple sclerosis and inflammatory central nervous system diseases | Q39695604 | ||
| Viral infections and demyelinating diseases | Q39897658 | ||
| Multiple Sclerosis as a Disease of Immune Regulation | Q40116465 | ||
| Cytomegalovirus as a frequent cause of Guillain-Barré syndrome | Q40135918 | ||
| The biochemistry and mechanism of action of acyclovir | Q40137953 | ||
| The pathogenesis of multiple sclerosis. Additional considerations | Q40488640 | ||
| Human leukocyte antigen studies in multiple sclerosis | Q40664843 | ||
| The virology of demyelinating diseases | Q40664855 | ||
| Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system | Q40729288 | ||
| Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 | ||
| Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. | Q40864697 | ||
| Identification of multiple sclerosis-associated genes | Q40878444 | ||
| Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). | Q41042764 | ||
| Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? | Q41087848 | ||
| The patterns of varicella zoster virus encephalitis | Q41118431 | ||
| B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. | Q41336689 | ||
| Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis | Q41588238 | ||
| The search for virus in multiple sclerosis brain | Q41622000 | ||
| Management of multiple sclerosis | Q41644495 | ||
| Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. | Q41733661 | ||
| Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls | Q41734490 | ||
| Current immunotherapy in multiple sclerosis | Q41745131 | ||
| Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system | Q41919381 | ||
| Multiple sclerosis and age at migration | Q41969958 | ||
| Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis | Q41985412 | ||
| Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation | Q42120954 | ||
| A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group | Q42682024 | ||
| Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus Infections | Q42985633 | ||
| Varicella zoster-associated neurologic disease without skin lesions | Q43414116 | ||
| Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. | Q43516919 | ||
| Bulbar encephalitis complicating trigeminal zoster in the acquired immune deficiency syndrome | Q43741449 | ||
| Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis | Q43876866 | ||
| Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis | Q43971442 | ||
| Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis | Q44046993 | ||
| Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis | Q44060297 | ||
| Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis | Q44284300 | ||
| Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction | Q44293211 | ||
| Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients | Q44917948 | ||
| The prevalence of locally-synthesized virus antibodies in various forms of multiple sclerosis | Q45052911 | ||
| Retroviral sequence located in border region of short unique region and short terminal repeat of Md5 strain of Marek's disease virus type 1. | Q45171245 | ||
| Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice | Q45222437 | ||
| Demyelinating disease after neurologically complicated primary Epstein‐Barr virus infection | Q45880664 | ||
| Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8 encephalitis in HIV-positive and -negative individuals. | Q45984226 | ||
| A case-control study of multiple sclerosis | Q46046272 | ||
| Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide | Q46654894 | ||
| Tumor necrosis factor-alpha response and herpesvirus infection in Bell's palsy | Q47675629 | ||
| Human herpesvirus-7 DNA in cerebrospinal fluid. | Q47865421 | ||
| Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation | Q47980468 | ||
| Vidarabine versus acyclovir therapy in herpes simplex encephalitis | Q48385636 | ||
| CSF immune complexes in multiple sclerosis | Q48519275 | ||
| Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome | Q48611413 | ||
| Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients | Q48621181 | ||
| Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult | Q48675872 | ||
| Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis | Q48713151 | ||
| Axonal damage in acute multiple sclerosis lesions | Q48776354 | ||
| Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions | Q48789208 | ||
| Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction | Q48955371 | ||
| Clinical viral infections and multiple sclerosis. | Q50560674 | ||
| Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. | Q50617947 | ||
| Multiple sclerosis and infectious childhood diseases. | Q50879198 | ||
| Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. | Q50952982 | ||
| The topography of plaques in multiple sclerosis with special reference to cerebral plaques | Q51264161 | ||
| A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. | Q53355861 | ||
| Measles antibodies in multiple sclerosis. | Q53778940 | ||
| Suppression of humoral immunity in chickens prevents transient paralysis caused by a herpesvirus | Q54498581 | ||
| Complex role of gamma-herpesviruses in multiple sclerosis and infectious mononucleosis | Q57110972 | ||
| Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study | Q58321120 | ||
| Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection | Q58321149 | ||
| T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis | Q59049915 | ||
| Multiple sclerosis and human T-cell lymphotropic retroviruses | Q59051051 | ||
| Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis | Q61657788 | ||
| Animal models | Q61709827 | ||
| Viral antibodies in multiple sclerosis | Q67398897 | ||
| Investigations of environmental conditions during cluster indicate probable vectors of unknown exogenous agent(s) of multiple sclerosis | Q67486699 | ||
| Homogeneous Susceptibility of Distinct Human Herpesvirus 6 Strains to Antivirals In Vitro | Q68237704 | ||
| Acyclovir concentrations in serum and cerebrospinal fluid at steady state | Q69440995 | ||
| A population-based study of multiple sclerosis in twins | Q69671085 | ||
| The intrathecal immune response in the early stage of multiple sclerosis | Q70367267 | ||
| Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro | Q70392550 | ||
| Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications | Q70456942 | ||
| Multiple sclerosis: remyelination of nascent lesions | Q70564751 | ||
| Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group | Q70650973 | ||
| Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis | Q70862364 | ||
| Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial | Q71126643 | ||
| Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient | Q71367409 | ||
| Restricted dissemination of clinically defined attacks in an MS incidence material | Q71994996 | ||
| Influence of infection on exacerbations of multiple sclerosis | Q72030057 | ||
| Neonatal herpes simplex virus infections | Q72621458 | ||
| Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients | Q72647019 | ||
| Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation | Q72816156 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-19 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Herpesviruses--a rationale for antiviral treatment in multiple sclerosis | |
| P478 | volume | 41 |
| Q48895814 | Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis |
| Q48637768 | Isolation and growth of a cytopathic agent from multiple sclerosis brain tissue |
| Q40039485 | Treatment of Theiler's virus-induced demyelinating disease with teriflunomide. |
| Q37961446 | Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis |
Search more.